Document:

Second Amendment to ZymoGenetics Deferred Compensation Plan for Key Employees

 Exhibit 10.3 
 SECOND AMENDMENT TO 
 ZYMOGENETICS 
 DEFERRED COMPENSATION PLAN FOR KEY EMPLOYEES 
 This Amendment is made to the
ZymoGenetics Deferred Compensation Plan for Key Employees (the “Plan”) which was originally effective November 1, 1992 and most recently amended and restated effective November 1, 1997. 
 Effective January 1, 2006, the first sentence of Article III.2(a) is amended by increasing the maximum percentage of salary a Participant may
defer from 15% to 50%. 
 IN WITNESS WHEREOF, ZymoGenetics, Inc. has caused this Amendment to be executed on the date indicated below.

  

									
		 		 	ZYMOGENETICS, INC.
				
	Dated: May 2, 2008	 		 	By:	 	/s/ Bruce L.A. Carter
		 		 		 		 	Bruce L.A. Carter
		 		 		 	Its:	 	Chairman and Chief Executive OfficerThird Amendment to ZymoGenetics Deferred Compensation Plan for Key Employees

 Exhibit 10.4 
 THIRD AMENDMENT TO 
 ZYMOGENETICS 
 DEFERRED COMPENSATION PLAN FOR KEY EMPLOYEES 
 This Amendment is made to the
ZymoGenetics Deferred Compensation Plan for Key Employees (the “Plan”) which was originally effective November 1, 1992 and most recently amended and restated effective November 1, 1997. 
 Effective January 1, 2008, Articles III(2)(a)(3) and (4) are amended to read as follows: 
 (3) Date of Payment. With respect to amounts withheld in Plan Years commencing on or after January 1, 2005, each Participation
Agreement will indicate the date for the payment of amounts withheld pursuant thereto, which date shall not be less than three (3) years from the date such Participation Agreement is executed. If a Participant does not indicate a date for
payment on a Participation Agreement, the amounts withheld pursuant thereto will be paid to him in one lump-sum within sixty (60) days after his termination of employment with the Company. A Participant may change the date on which amounts
subject to Internal Revenue Code Section 409A (i.e., amounts withheld in 2005, 2006, 2007 and/or 2008 (and earnings, gains and losses thereon)) are paid or commence to be paid to the extent permitted in applicable IRS guidance so long as
(i) the Participant does so on or before December 31, 2008 in accordance with such rules as the Administrator shall establish and (ii) such change does not have the effect of (A) deferring payment of any amount that would
otherwise be paid in the year the Participant files such election with the Administrator to a future year and (B) accelerating payment any amount that would otherwise be paid in a future year into the year in which the Participant files such
election with the Administrator. 
 (4) Form of Payment. Distribution of amounts withheld during a year commencing on
or after January 1, 2005 pursuant to a Participation Agreement will be made either in one lump-sum or in annual installments over a period of up to ten (10) years, as selected by the Participant on the Participation Agreement. A
Participant may make separate elections for amounts withheld in each calendar year. If distributions are made in annual installments over a period of years, the amount of each annual installment will be determined by the Administrator, by dividing
the portion of Participant’s Account Balance which is payable in installments, measured immediately before an installment payment, by the number of installments remaining to be paid. A Participant may change the form in which amounts subject to
Internal Revenue Code Section 409A (i.e., amounts withheld in 2005, 2006, 2007 and/or 2008 (and earnings, gains and losses thereon)) are paid to the extent 

 
permitted in applicable IRS guidance so long as (i) the Participant does so on or before December 31, 2008 in accordance with such rules as the
Administrator shall establish and (ii) such change does not have the effect of (A) deferring payment of any amount that would otherwise be paid in the year the Participant files such election with the Administrator to a future year and
(B) accelerating payment of any amount that would otherwise be paid in a future year into the year in which the Participant files such election with the Administrator. 
 IN WITNESS WHEREOF, ZymoGenetics, Inc. has caused this Amendment to be executed on the date indicated below. 
  

									
		 		 	ZYMOGENETICS, INC.
				
	Dated: December 20, 2007	 		 	By:	 	/s/ Bruce L.A. Carter
		 		 		 		 	Bruce L.A. Carter, Ph.D.
		 		 		 	Its:	 	Chief Executive Officer

  

 -2-2008 Executive Officer compensation arrangements

 Exhibit 10.32 
 2008 Base Salaries for Named Executive Officers 
 The
Compensation Committee of the Board of Directors (the “Committee”) annually sets forth compensation levels and equity awards for the Company’s executive officers using the following process: after reviewing the data set forth in a
compensation survey provided by Radford Surveys + Consulting, a global life sciences and technology industry compensation consulting firm, the Committee determines on an annual basis for each executive officer, (1) a target total compensation
package, (2) the appropriate allocation of the total compensation package between base salary, short-term performance based compensation and long-term equity incentive compensation, and (3) whether there should be any changes to the
compensation packages to better align our executive officers’ interests with those of our stockholders. Adjustments to the base salary of our executive officers is determined by the Committee in February of each year, with the adjustments
becoming effective March 1st. For 2008, the Committee approved the salaries listed below for each of the Company’s named executive
officers. 
  

				
	 Named Executive Officer
	  	Base Salary for 2008
	Claes Glassell	  	$	490,000
	 President and Chief Executive Officer
	  		
		
	William J. Dawson	  	$	293,273
	 Vice President, Finance and Chief Financial Officer
	  		
		
	Laurence M. Corash, M.D.	  	$	375,000
	 Vice President, Medical Affairs and Chief Medical Officer
	  		
		
	William M. Greenman	  	$	312,000
	 President, Cerus Europe
	  		
		
	Howard G. Ervin	  	$	311,531
	 Vice President, Legal AffairsSupply Agreement

 EXHIBIT 10.33 
 [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY
BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND
EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934,
AS AMENDED. 
 SUPPLY AGREEMENT 
 THIS SUPPLY AGREEMENT
(THE “SUPPLY AGREEMENT”) is made effective as of the 19th day of
December, 2007 (the “Effective Date”) by and between Cerus Corporation (“Cerus”), a Delaware corporation, having its principal place of business at 2411 Stanwell Drive, Concord, CA 94520, and Brotech Corporation dba
Purolite Company (“Purolite”), a Delaware corporation, having its principal place of business at 150 Monument Road, Bala Cynwyd, PA 19004. (Cerus and Purolite are each individually referred to in this Supply Agreement as a
“Party” and, collectively, as the “Parties”). 
 WITNESSETH 
 WHEREAS, Cerus develops, markets and sells products and technology for the inactivation of pathogens in blood and blood components,
and Purolite is a global manufacturer and supplier of specialty resins; 
 WHEREAS, the Parties desire to set forth the
terms under which Cerus may purchase from Purolite [ * ] and [ * ] (collectively, the “Raw Materials”) made to Cerus specifications as further detailed, respectively in Exhibit A and Exhibit B attached
hereto (the “Specifications”); 
 WHEREAS, the Raw Materials will be used in the manufacture of
disposable products forming part of the INTERCEPT Blood System for platelets and the INTERCEPT Blood System for plasma, respectively, for sale by Cerus and its affiliates, and disposable products forming part of similar systems for sale by a third
party (collectively, the “Products”); 
 NOW
THEREFORE, in consideration of the foregoing premises and the mutual covenants set forth herein, Cerus and Purolite agree as follows: 
  

	1.	PURCHASES 

 1.1
Purchase and Sale 
 During the term of this Supply Agreement, Purolite shall sell to Cerus Raw Materials ordered pursuant to
Section 1.2 of this Agreement. Cerus may designate, from time to time, one or more third parties (hereinafter referred to as “Designee”) that are authorized to receive, inspect and test shipments from Purolite for such ordered
Raw Materials, pursuant to Section 2. 
  

 Page 1 of 16 
 CERUS –PUROLITE AGMT. 

 1.2 Forecasts/Purchase Orders 
 No later than the end of third quarter of each calendar year, Cerus will provide Purolite with written rolling [ * ] month [ * ] forecasts
of its requirements of Raw Materials for the following [ * ] (each a “Forecast”), including requested delivery dates. On or before the end of each calendar quarter during the term of this Agreement, Cerus will provide a
binding [ * ] order for the immediately following calendar quarter, with delivery dates (“Purchase Order(s)”) and a non-binding [ * ] forecast, with monthly delivery dates. Within ten (10) business days after
receipt of the Purchase Order, Purolite shall provide confirmation of its ability to meet the monthly requirements in the Purchase Order. All sales of Raw Materials shall be subject to the terms and conditions of this Agreement and, to the extent
they specify quantities, destinations and delivery dates, to Cerus’ purchase orders, as the case may be. 
  

	2.	DELIVERY AND ACCEPTANCE 

 The process flow charts illustrating the manufacturing and release processes for the Raw Materials are attached hereto as Exhibit C, subject to change by mutual written agreement of the Parties. 
 2.1 Testing and Release of Raw Materials 
 Purolite shall ship a representative sample of each batch of Raw Materials produced with all relevant documentation (including Batch Record and Certificate of Analysis) to Designee’s testing facility for testing as further detailed in
the “Quality Obligations” provided in Exhibit D attached hereto. If the analysis of the sample batch performed by Designee indicates that said batch does not meet Specifications or is otherwise non-conforming, Cerus shall
provide written notification of such to Purolite. A Certificate of Analysis shall be issued to Cerus for each accepted batch. 
 2.2
Shipment 
 Purolite shall, upon notification by Cerus, ship released batches for said materials to the location designated by Cerus in
the respective purchase order, using a mutually agreed carrier, [ * ]. Title and risk of loss to the Raw Materials shall pass to Cerus [ * ] made by Purolite. Unless otherwise agreed to in writing, Cerus shall pay all shipping charges.
Purolite shall provide Cerus with all documentation necessary to accomplish shipment to such designated locations as further described in the Specifications. Should Purolite be unable to provide Raw Materials by the agreed upon date of shipment on
purchase orders within agreed upon lead time, Purolite will bear the cost premium freight (including airfreight) to deliver the Raw Materials to Cerus’ final destination, as specified in the purchase order. 
 2.3 Quality Assurance 
 2.3.1
All Raw Materials shipped hereunder shall meet the Specifications and shall be subjected to a quality control inspection and final release by Purolite in accordance with the Quality Obligations set forth in Exhibit D attached hereto, and
Purolite shall maintain compliance with said Quality Obligations. If Cerus or said Designee rejects Products as a result of Raw Materials non-conformance, Cerus shall notify Purolite in writing within 60 days. At Cerus option and at Purolite’s
expense, as the case may be, Cerus shall receive a credit, refund or replacement for such Raw Materials if the non-conformance can be directly attributed to Purolite’s Raw Materials. 
  

 Page 2 of 16 
 CERUS –PUROLITE AGMT. 
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 

 2.3.2 Purolite shall permit Cerus to review periodically Purolite’s production and quality
control procedures and records and to visit Purolite’s facilities at reasonable times with a representative of Purolite present in order to assure satisfaction of the requirements of this Agreement. Purolite will also notify Cerus immediately
of any inspection of its facilities by a federal, state or local regulatory agency as well as the results of such inspection. 
 2.3.3
In the event that either Party receives any complaint regarding the Raw Materials, it shall notify the other Party promptly. Purolite will be responsible for evaluating these complaints and responding to Cerus in writing. Cerus will make a
preliminary evaluation of each complaint it receives and will conduct all follow-up and communicating which it deems appropriate. 
  

	3.	PAYMENT 

 Prices to be paid by Cerus
(the “Prices”) are set forth on Exhibit E. Immediately following each shipment, Purolite shall invoice Cerus for Raw Materials produced, released and shipped in accordance with this Agreement and pursuant to Cerus’ Purchase
Order for that shipment. Cerus will pay the amount of the invoice within [ * ] days of receipt by Cerus of proof of delivery at destination point of Raw Materials covered by such invoice, sent by Purolite. Any pricing adjustment will be
reflected in the invoice following the date the Parties determine such adjustment is appropriate. 
  

	4.	RAW MATERIAL CHANGES 

 4.1 Purolite shall notify Cerus in advance and in writing of any proposed change in the following aspects of the Raw Materials or their components: (i) composition or source of any raw material;
(ii) method of producing, processing or testing; (iii) change in subcontractors for producing, processing or testing; (iv) site of manufacture; (v) labeling. No such change shall be made without Cerus’ prior written consent.

 4.2 Purolite shall make available to Cerus all developments or enhancements to the Products and other products that accomplish the
same or similar functions as the Products. If Cerus shall agree in writing to accept any such enhancement, development or other product, it shall be added as an amendment to their respective Specifications. Changes in the price of Products as a
result of enhancements or developments accepted by Cerus shall be mutually agreed in writing. 
  

 Page 3 of 16 
 CERUS –PUROLITE AGMT. 
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 

	5.	FORCE MAJEURE 

 Purolite shall not be liable for delays in performance or for non-performance of its obligations hereunder if prevented by unforeseeable causes outside of its reasonable control. Without limiting the foregoing, such causes shall include but
not be limited to, acts of God or the public enemy, fires, floods, earthquake, riots, boycotts, strikes, lock-outs, and delays in transportation or shortage of supplies necessary for production, in each case where delays could not reasonably have
been prevented. Upon discovering that timely performance will be delayed, Purolite will immediately notify Cerus of the nature of the delay and Purolite’s disaster recovery plan along with timing expectations. Purolite will develop and furnish
to Cerus a copy of a proposed disaster recovery plan promptly following execution of this Supply Agreement. 
  

	6.	WARRANTIES AND INDEMNIFICATIONS 

 6.1 Purolite Warranties 
 6.1.1 PUROLITE WARRANTS THAT PUROLITE TRANSFERS GOOD AND MARKETABLE
TITLE TO THE RAW MATERIALS SOLD TO CERUS UNDER THIS AGREEMENT AS OF THE TIME THAT PUROLITE SHIPS SUCH RAW MATERIALS. THE WARRANTIES IN THIS SECTION 6.1.1 ARE IN LIEU OF ALL OTHER WARRANTIES, EXPRESS OR IMPLIED, WHICH ARE HEREBY DISCLAIMED AND
EXCLUDED BY PUROLITE, INCLUDING ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, OR ANY WARRANTY ARISING FROM COURSE OF PERFORMANCE, COURSE OF DEALING OR USAGE OF TRADE. 
 6.1.2 All Raw Materials provided to Cerus are hereby guaranteed by Purolite, as of the date of shipment or delivery, to meet the Specifications
and requirements specified by Cerus under this Supply Agreement and, to be, on such date, not adulterated or misbranded. 
 6.2
Indemnification 
 6.2.1 Cerus, will indemnify, defend and hold harmless Purolite, its affiliates, and their respective officers,
directors, agents, and employees (each a “Purolite Indemnified Party”) from and against any and all claims, actions and causes of action from third parties, and liabilities, losses, costs, damages or expenses (including reasonable
attorney’s fees) arising therefrom out of or in consequence of (i) the possession or use of any Products containing the Raw Materials, except to the extent caused by a matter covered by Purolite’s indemnity in Section 6.2.2;
(ii) the death of or bodily injury to any person on account of the use of any Product containing the Raw Materials, except to the extent caused by a matter covered by Purolite’s indemnity in Section 6.2.2; or, (iii) any claim
that the Products violate a patent or trademark. However, Cerus shall not be obligated to indemnify a Purolite Indemnified Party from any liability to the extent caused by a Purolite Indemnified Party’s negligence or misconduct. 
 6.2.2 Purolite will indemnify, defend and hold harmless Cerus and its respective officers, directors, agents, employees and affiliates (each a
“Cerus Indemnified Party”) from and against any and all third party claims, actions, causes of action, liabilities, losses, costs, damages or expenses (including reasonable attorney’s fees) to the extent arising out of or in
consequence of any (a) claim of patent or trade secrets infringement which relates to the Raw Materials. However, Purolite shall not be obligated to indemnify a Cerus Indemnified Party from any liability to the extent caused by such Cerus
Indemnified Party’s negligence or misconduct. 
  

 Page 4 of 16 
 CERUS –PUROLITE AGMT. 
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 
  

 6.2.3 Each Party agrees to give the other Party prompt written notice of any claims, including any
claims asserted or made by any governmental authority, for which the other might be liable under the foregoing indemnification, together with the opportunity to defend, negotiate and settle such claims. Such notice shall be given to the other Party
promptly after receipt of such claim. Failure to provide or promptly provide such notice shall not release the other Party from any of its obligations hereunder except to the extent that the indemnifying Party is materially prejudiced by such
failure. Each Party will cooperate fully with the other Party in defending or otherwise resolving any such action, and each indemnified Party in any such action may at its option and expense be represented in such action. 
 6.3 Insurance 
 Each Party shall
obtain and keep in force during the term of this Agreement [ * ] comprehensive liability insurance covering each occurrence of bodily injury (including death) and property damage in an amount of not less than $[ * ] combined in a
single limit, including: 
 (i) Products and Completed Operations Liability; and 
 (ii) Contractual Liability. 
 The insurance policy shall be endorsed to name the other Party as additional insured and to provide for written notification to the other parties by the insurer not less than thirty (30) days prior to cancellation, expiration or
modification. If requested in writing, a certificate of insurance evidencing compliance with this Section and referencing this Supply Agreement shall be furnished to each Party. 
  

	7.	DISCLOSURE OF INFORMATION; INTELLECTUAL PROPERTY 

 7.1 Purolite shall maintain in confidence information received prior to and in the course of this Agreement from Cerus or its Designee(s) relating
to Cerus, including, but not limited to, Cerus’ supply chain and business activities (“Confidential Information”) and shall not disclose the same to any third party or use the same except for the purposes of this Agreement. The
term “Confidential Information” shall not be deemed to include information which: 
 (a) is now, or hereafter
becomes, through no act or failure to act on the part of Purolite, generally known or available; 
 (b) is known by Purolite
at the time of receiving such information, as evidenced by his or her written records; 
  

 Page 5 of 16 
 CERUS –PUROLITE AGMT. 
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 
  

 (c) is hereafter furnished to Purolite by a third party, as a matter of right and without
restriction of disclosure; or 
 (d) is the subject of a written permission to disclose provided by Cerus. 
 Purolite understands and agrees that this Supply Agreement is not intended to grant Purolite any right, title, interest or license to use or disclose Cerus’
Confidential Information and intellectual property, including, but not limited to Products designs and Specifications. 
 7.2 Unless
otherwise agreed in writing, all information concerning the Raw Materials disclosed by Purolite prior to or during the term of the Agreement is disclosed on a nonconfidential basis. Cerus understands and agrees that this Supply Agreement is not
intended to grant Cerus any right, title, interest or license to use Purolite’s manufacturing processes. 
  

	8.	TERM; TERMINATION 

 8.1 This Supply Agreement will have a term (the “Initial Term”) which will run for seventy-two (72) months commencing on the Effective Date, subject to extension as provided in Section 8.2. 
 8.2 At the end of the Initial Term and each renewal term, this Supply Agreement shall automatically renew from year to year for successive one
(1) year periods, unless either Party shall have given the other Party written notice of non-renewal at least two years prior to the last day of the Initial Term or renewal term, as the case may be. 
 8.3 If a Party materially breaches this Supply Agreement and such breach remains uncured for a period of ninety (90) days after written
notice containing details of the breach is delivered to the breaching Party, then the non-breaching Party may terminate this Supply Agreement as to the breaching Party by further notice delivered no later than thirty (30) days after the
expiration of the initial ninety (90) day cure period. 
 8.4 The provisions of Articles 6 and 7 of this Supply Agreement shall
survive termination of the Supply Agreement and remain in effect in accordance with their terms. 
  

	9.	MISCELLANEOUS 

 9.1 Entire
Agreement 
 This Supply Agreement contains the entire agreement between the Parties relating to the Raw Materials and supersede all
prior agreements and negotiations between Cerus and Purolite regarding the same. None of the terms of this Supply Agreement shall be deemed to be waived or amended by any Party unless such a waiver or amendment specifically references this Supply
Agreement and is in writing signed by the Party to be bound. 
  

 Page 6 of 16 
 CERUS –PUROLITE AGMT. 
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 
  

 9.2 Notices 
 All notices and demands required or permitted to be given or made pursuant to this Supply Agreement shall be in writing and effective when personally given or when placed in an envelope and deposited in the United
States mail postage prepaid and return receipt requested, or delivered by a recognized commercial courier service, addressed as follows: 
 If to Cerus:

 Chief Executive Officer 
 Cerus Corporation 
 2411 Stanwell Drive 
 Concord, CA 94520 
 cc: Vice President, Legal Affairs by fax ([ * ]) 
 If to Purolite:

 Ted Begg, Sales Mgr. 
 The Purolite Company 
 150 Monument Road 
 Bala Cynwyd, PA 19004 
 cc: Jacob Brodie, Vice President by fax 484 384 2751 
 or to such other
address as to which either Party may notify the other. 
 9.3 Assignment 
 This Supply Agreement shall be binding upon and inure to the benefit of the Parties, their successors and assigns. This Supply Agreement shall be
assignable: (i) by any Party to an affiliate of the Party, in whole or in part, without the consent of the other Party; (ii) by any Party with the written consent of the other Party; or (iii) by any Party without the consent of the
other Party to the purchaser of substantially all the assets of its business to which this Supply Agreement relates or to any corporate successor to a Party by merger, consolidation or otherwise. Any attempted assignment that does not comply with
the terms of this Section shall be void. Each Party shall cause this Supply Agreement to be assumed by any business organization that purchases its operations supporting this Supply Agreement or to any corporate successor to a Party by merger,
consolidation or otherwise. Despite any assignment under this Section, the Party making the assignment shall remain liable for its obligations as a Party to this Supply Agreement. 
  

 Page 7 of 16 
 CERUS –PUROLITE AGMT. 
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 
  

 9.4 Governing Law 
 This Supply Agreement is deemed to have been executed in and shall be governed by and construed in accordance with the Uniform Commercial Code as enacted in the State of New York and other applicable laws of the State
of New York. If particular portions of this Supply Agreement are ruled unenforceable, such portions shall be deleted and all other terms and conditions of this Supply Agreement shall remain in full force and effect. 
 9.5 Independent Contractors; Relationship of Parties 
 9.5.1 The relationship of the Parties under this Supply Agreement shall be and at all times remains one of independent contractors. No Party is an employee, agent or legal representative of any other Party or
shall have any authority to assume or create obligations on any other Party’s behalf. 
 9.5.2 Cerus shall have the right to
revoke any designation as a Designee made pursuant to Subsection 1.1 of this Agreement, which revocation shall be effective thirty (30) days following written notice of such to Purolite. 
 9.5.3 Nothing herein shall be construed as giving any Designee any rights, interest or claims hereunder or be entitled to any benefits under or on
account of the Agreement as a third-party beneficiary or otherwise and the sole and intended beneficiaries of this Agreement and the Supply Agreement are Cerus and Purolite. 
  

 Page 8 of 16 
 CERUS –PUROLITE AGMT. 
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 
  

 IN WITNESS WHEREOF, the parties have executed this
Supply Agreement in counterparts, effective as of the day and year first written above. 
  

			
	CERUS CORPORATION
		
	By:	 	/s/ William J. Dawson
		
	Name:	 	William J. Dawson
		
	Title:	 	Chief Financial Officer
	
	PUROLITE CORPORATION
		
	By:	 	/s/ Jacob Brodie
		
	Name:	 	Jacob Brodie
		
	Title:	 	Vice President

  

 Page 9 of 16 
 CERUS –PUROLITE AGMT. 
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 
  

 Exhibit A 
 Specifications for [ * ] 
 {Attached separately} 
 [ * ] 
  

 EXHIBIT A 
 CERUS –PUROLITE AGMT. 
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 
  

 Exhibit B 
 [ * ] 
 {ATTACHED SEPARATELY}

 [ * ] 
  

 EXHIBIT B 
 CERUS –PUROLITE AGMT. 
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 
  

 Exhibit C — Plasma Disk: Forecasting, Purchasing, Materials Process Flow 
 [ * ] 
  

 EXHIBIT C 
 CERUS –PUROLITE AGMT. 
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 
  

 Exhibit C — Platelet Wafer: Forecasting, Purchasing, Materials Process Flow (Cont’d) 

 [ * ] 
  

 EXHIBIT C 
 CERUS –PUROLITE AGMT. 
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 
  

 Exhibit D 
 Quality Obligations 
 The following is to set forth responsibilities of Cerus and Purolite with respect to Quality
Obligations. 
  

	(A)	Cerus (directly or through its Designee) Responsibilities: 

  

	1.	Provide Purolite with current, approved regulatory documents including Specifications. 

  

	2.	Approve manufacturing batch records, review validation documents and other manufacturing documents as applicable. If changes are indicated, provide edited copies to Purolite to
facilitate revision. 

  

	3.	Cerus or its Designee will analyze pre-shipment samples of Product within [ * ] of receipt of said samples at the designated testing facility. Cerus will provide Purolite
with the analysis data and if the Product is approved, will provide a written release of the Product Lots for shipment. If Product Lots are rejected, Cerus will provide an explanation of the rejection along with the analysis data.

  

	4.	Inspect and test all Raw Materials shipped hereunder and notify Purolite of any Raw Materials that does not comply with the Specifications within sixty (60) days from delivery.
Such notice shall specify the reasons for rejection, and Cerus or Designee giving notice (as the case may be) shall thereafter (insofar as they are in its possession and with Purolite’s approval) return the rejected Raw Materials to Purolite at
Purolite’s risk and expense. If Cerus or Designee (as the case may be) do not deliver such written notice of rejection within such sixty (60)-day period, Cerus shall be deemed to have accepted the shipment. In the event that Cerus or Designee
(as the case may be) delivers notice to Purolite that Cerus or said Designee has rejected any shipment, Cerus or said Designee (as the case may be) shall promptly make available to Purolite for examination and testing the Raw Materials contained in
such rejected shipment (excluding units consumed in such Designee testing), and Purolite shall, within ninety (90) days, replace the defective and non-conforming Raw Materials contained in such shipment and return such Raw Materials to Cerus or
said Designee (as the case may be), transportation and insurance prepaid. 

  

	(B)	Purolite Responsibilities: 

  

	1.	Maintain specifications and test methods according to Purolite SOPs and where applicable, according to mutually agreed upon specifications. 

  

	2.	Sample and maintain reserve samples per the Specifications. 

  

 EXHIBIT D 
 CERUS –PUROLITE AGMT. 
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 
  

	3.	Test and perform quality release of Raw Materials and finished products according to Purolite SOPs and approved specification requirements. 

  

	4.	Provide prior notification to and obtain written approval from Cerus Quality Assurance of any change to production or test records, Raw Material Specifications, test methods or
location relating to manufacture of Products. 

  

	5.	Perform testing as directed by approved master records, protocols, or validated analytical test procedures. 

  

	6.	Maintain reasonable manufacturing records as agreed to by Cerus. 

  

	7.	Perform cleaning and process validation as applicable per protocol (which shall be reviewed by Cerus prior to final approval by Purolite). 

  

	8.	Review and forward all deviation reports to Cerus for review as part of batch record documentation. 

  

	9.	Review and forward copy of executed batch records, test records, Certificates of Analysis, and related documents, as required, to Cerus for review. 

  

	10.	Provide evidence of ISO 9001 certification, if requested. 

  

	11.	Maintain facility and critical systems in a current state of compliance and validation per ISO 9001 requirements. 

  

	12.	Agree to regular audits (no more frequently than annually or for cause) by Cerus at mutually acceptable times. 

  

	13.	Support Cerus regulatory submissions by providing information requested in a timely manner provided such submissions do not require Purolite to provide Purolite Confidential
Information or trade secrets. 

  

	14.	Notify Cerus, within ten (10) business days, of pending ISO or FDA audits that may affect the supply of Raw Materials under this Agreement. Provide results of any ISO or FDA
audit related to Cerus manufacturing. 

  

 EXHIBIT D 
 CERUS –PUROLITE AGMT. 
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 
  

 Exhibit E 
 Pricing 
  

	1.	[ * ] Pricing 

 [ * ] price will remain at $[ * ] until
Cerus [ * ] Pricing for these [ * ] will decrease according to the following schedule after the aforementioned requirement is satisfied. 
  

			
	 Quantity
	  	 Price

		
	[ * ]	  	[ * ]

  

	2.	Contract Grinding & Classification 

 [ * ] will be ground
to [ * ] and further classified to a [ * ] for production of [ * ]. Pricing for these operations are as follows and is based on the [ * ] that is ground to produce [ * ]. 
 Grinding- $[ * ] of [ * ] 
 Classification-
$[ * ] of [ * ] 
 Pricing for extension terms will be negotiated in good faith between Cerus and Purolite. Pricing negotiation will take into
account any increases in Purolite’s costs of raw materials and labor and any decrease in costs association with achievement of manufacturing efficiencies. In the event the Parties are unable to agree on pricing, such determination shall be made
by a third party (not a competitor to Purolite) to be designated by the Parties by arbitration administered by the American Arbitration Association in accordance with its Commercial Arbitration Rules 
  

 EXHIBIT E 
 CERUS –PUROLITE AGMT. 
 [ * ] = CERTAIN
CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}]]